Vistatec Life Sciences is pleased to return to SCOPE Summit 2026, one of the most important events in the global clinical research calendar.
SCOPE takes place February 2-5, 2026, at Rosen Shingle Creek in Orlando, Florida. It brings together leaders across pharma, biotech, CROs, sites, technology, and patient advocacy. It is also one of the most active networking environments in the industry.
We have attended SCOPE for several years in a row. Each year, the conversations get sharper, faster, and more urgent as clinical research evolves. Teams are under pressure to deliver more with less. At the same time, patients are demanding better experiences and more transparency.
That is exactly why we value SCOPE. It is where clinical research connects.
The SCOPE Summit in 2026
Clinical trials remain the engine of medical progress. However, the way trials are designed and delivered is changing.
SCOPE reflects that shift. It is not a single-track event but rather an ecosystem. And it is designed for real operational conversations.
In 2026, the program includes:
- 30 Conference tracks, including new additions such as Market Access and Safety
- 300+ Exhibitors across the full clinical research ecosystem
- A packed schedule of panels, networking sessions, and awards
- High-demand themes, including protocol optimization, patient engagement, RBQM, and generative AI
SCOPE also continues to attract senior decision-makers. In many industries, events become overly vendor-focused. SCOPE is different; you meet people who are building, running, and improving trials at scale.
The Topics People Are Worried About Right Now
SCOPE is always a temperature check for the industry, and this year is no different.
Based on the latest agenda themes, we expect a strong focus on:
Patient engagement and recruitment
Sites are stretched. Recruitment is still slow for many studies. And sponsors are under pressure to diversify participation. That means patient communication needs to work in the real world, not just on paper.
Protocol complexity and trial burden
Protocol design is a major lever for cost and speed. Yet many protocols still increase the burden unnecessarily. Better planning reduces amendments. It also improves retention.
Global trial execution
More trials involve multiple countries and cultures. That creates friction when content is unclear, inconsistent, or poorly adapted. In short, the global scale makes communication harder.
Generative AI and operational adoption
Many organizations are moving past experimentation. Now, the key questions are about governance, quality, and impact. Teams want AI to help, but not at the cost of compliance or trust.
These are not abstract problems. They are day-to-day challenges. They shape timelines, budgets, and outcomes.
Where Vistatec Life Sciences Fits In
At Vistatec Life Sciences, we work with teams that carry high responsibility. These include clinical operations, regulatory, quality, and patient engagement leaders.
We help life sciences organizations scale global communication across the product lifecycle.
That includes:
- Clinical trial content translation and localization
- Patient-facing communication in plain language
- Quality-focused workflows for high-risk content
- Multilingual alignment across regions and markets
In addition, we support teams exploring AI in localization. We do it with a responsible, human-centered approach. That means strong governance. It also means measurable quality. In life sciences, outcomes depend on precision.
Visit Us at Booth 635
If you are attending SCOPE 2026, we would love to meet you in person.
Karen Tkaczyk, Rossana Kale, and Maria Roa will represent Vistatec Life Sciences on site. They will be available throughout the event to speak with attendees and discuss what is coming next in clinical research communication and global execution.
Come find us at the booth if you want to talk about:
- Patient-centric trial communication across languages
- Reducing friction in global trial operations
- Supporting trial speed without compromising quality
- AI, governance, and scalable multilingual workflows
We are always happy to share what we are seeing in the market.
Visit us at booth 635.
See You at SCOPE
SCOPE remains one of the best places to learn what is changing in clinical research. More importantly, it is where you hear what is working.
We are looking forward to returning once again. We are also looking forward to the conversations.
If you will be in Orlando this February, come meet us at the Vistatec Life Sciences booth. We would be delighted to connect.